Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer. |
Synonyms | BEY1107 trihydrochloride |
Molecular Weight | 390.65 |
Formula | C13H14Cl3N7O |
CAS No. | 1983984-01-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Avotaciclib trihydrochloride 1983984-01-5 BEY 1107 BEY 1107 Trihydrochloride BEY1107 trihydrochloride BEY1107 BEY1107 Trihydrochloride BEY-1107 Trihydrochloride Avotaciclib Trihydrochloride BEY-1107 Avotaciclib inhibitor inhibit